Rank | Gene Set | Z-score |
---|---|---|
1 | L-phenylalanine catabolic process (GO:0006559) | 4.78535984 |
2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.78535984 |
3 | L-phenylalanine metabolic process (GO:0006558) | 4.34500309 |
4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.34500309 |
5 | aromatic amino acid family catabolic process (GO:0009074) | 3.89705454 |
6 | establishment of protein localization to Golgi (GO:0072600) | 3.84802326 |
7 | keratinocyte development (GO:0003334) | 3.80423573 |
8 | protein targeting to Golgi (GO:0000042) | 3.78943749 |
9 | positive regulation of glycolytic process (GO:0045821) | 3.77607879 |
10 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 3.65492969 |
11 | bile acid biosynthetic process (GO:0006699) | 3.51750051 |
12 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.45938080 |
13 | alpha-linolenic acid metabolic process (GO:0036109) | 3.30579209 |
14 | tryptophan catabolic process (GO:0006569) | 3.28196616 |
15 | indole-containing compound catabolic process (GO:0042436) | 3.28196616 |
16 | indolalkylamine catabolic process (GO:0046218) | 3.28196616 |
17 | kynurenine metabolic process (GO:0070189) | 3.18571702 |
18 | complement activation, alternative pathway (GO:0006957) | 3.08530218 |
19 | short-chain fatty acid metabolic process (GO:0046459) | 3.07858327 |
20 | tryptophan metabolic process (GO:0006568) | 3.06357335 |
21 | cysteine metabolic process (GO:0006534) | 3.06212098 |
22 | regulation of skeletal muscle contraction (GO:0014819) | 3.04546789 |
23 | high-density lipoprotein particle remodeling (GO:0034375) | 3.04153837 |
24 | coenzyme catabolic process (GO:0009109) | 3.00928537 |
25 | glutamate metabolic process (GO:0006536) | 3.00175660 |
26 | bile acid metabolic process (GO:0008206) | 2.98185084 |
27 | regulation of protein activation cascade (GO:2000257) | 2.95621094 |
28 | neural tube formation (GO:0001841) | 2.95383929 |
29 | regulation of protein glycosylation (GO:0060049) | 2.91216505 |
30 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.91089942 |
31 | cellular ketone body metabolic process (GO:0046950) | 2.89718811 |
32 | protein carboxylation (GO:0018214) | 2.88435641 |
33 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.88435641 |
34 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.85740839 |
35 | regulation of fibrinolysis (GO:0051917) | 2.85044371 |
36 | glyoxylate metabolic process (GO:0046487) | 2.84616467 |
37 | protein localization to Golgi apparatus (GO:0034067) | 2.83606156 |
38 | regulation of hexokinase activity (GO:1903299) | 2.81620134 |
39 | regulation of glucokinase activity (GO:0033131) | 2.81620134 |
40 | dopamine transport (GO:0015872) | 2.80983767 |
41 | regulation of complement activation (GO:0030449) | 2.79361183 |
42 | reverse cholesterol transport (GO:0043691) | 2.78340470 |
43 | sulfur amino acid catabolic process (GO:0000098) | 2.76751240 |
44 | urea metabolic process (GO:0019627) | 2.75066195 |
45 | urea cycle (GO:0000050) | 2.75066195 |
46 | regulation of energy homeostasis (GO:2000505) | 2.74952066 |
47 | regulation of relaxation of muscle (GO:1901077) | 2.74536133 |
48 | homocysteine metabolic process (GO:0050667) | 2.73364334 |
49 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.73286251 |
50 | regulation of triglyceride catabolic process (GO:0010896) | 2.73011462 |
51 | tyrosine metabolic process (GO:0006570) | 2.72409124 |
52 | negative regulation of fibrinolysis (GO:0051918) | 2.70775078 |
53 | acylglycerol homeostasis (GO:0055090) | 2.68926803 |
54 | triglyceride homeostasis (GO:0070328) | 2.68926803 |
55 | alpha-amino acid catabolic process (GO:1901606) | 2.67524995 |
56 | aromatic amino acid family metabolic process (GO:0009072) | 2.66518249 |
57 | macroautophagy (GO:0016236) | 2.65981782 |
58 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.64682156 |
59 | cellular modified amino acid catabolic process (GO:0042219) | 2.62674097 |
60 | nitric oxide mediated signal transduction (GO:0007263) | 2.62626957 |
61 | regulation of germinal center formation (GO:0002634) | 2.62414854 |
62 | Golgi to endosome transport (GO:0006895) | 2.61500480 |
63 | muscle filament sliding (GO:0030049) | 2.61380032 |
64 | actin-myosin filament sliding (GO:0033275) | 2.61380032 |
65 | early endosome to late endosome transport (GO:0045022) | 2.60392042 |
66 | negative regulation of lipase activity (GO:0060192) | 2.60208346 |
67 | negative regulation of protein activation cascade (GO:2000258) | 2.59822858 |
68 | dicarboxylic acid catabolic process (GO:0043649) | 2.59587853 |
69 | plasma lipoprotein particle remodeling (GO:0034369) | 2.58759555 |
70 | protein-lipid complex remodeling (GO:0034368) | 2.58759555 |
71 | macromolecular complex remodeling (GO:0034367) | 2.58759555 |
72 | phospholipid efflux (GO:0033700) | 2.58343259 |
73 | protein K11-linked deubiquitination (GO:0035871) | 2.57522788 |
74 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.57223900 |
75 | regulation of lipoprotein metabolic process (GO:0050746) | 2.56350842 |
76 | cellular amino acid catabolic process (GO:0009063) | 2.56236058 |
77 | nitrogen cycle metabolic process (GO:0071941) | 2.54871898 |
78 | regulation of bile acid biosynthetic process (GO:0070857) | 2.53995966 |
79 | lysine metabolic process (GO:0006553) | 2.53918674 |
80 | lysine catabolic process (GO:0006554) | 2.53918674 |
81 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.53384539 |
82 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.52780834 |
83 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.52780834 |
84 | negative regulation of protein oligomerization (GO:0032460) | 2.51489536 |
85 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.51286447 |
86 | skeletal muscle tissue regeneration (GO:0043403) | 2.50351562 |
87 | relaxation of cardiac muscle (GO:0055119) | 2.50230146 |
88 | acetyl-CoA metabolic process (GO:0006084) | 2.50128966 |
89 | ketone body metabolic process (GO:1902224) | 2.50073304 |
90 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.49183083 |
91 | prostate gland growth (GO:0060736) | 2.48875760 |
92 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.48526523 |
93 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.47849944 |
94 | actin-mediated cell contraction (GO:0070252) | 2.47237026 |
95 | cholesterol efflux (GO:0033344) | 2.46843644 |
96 | intra-Golgi vesicle-mediated transport (GO:0006891) | 2.45859257 |
97 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.45041007 |
98 | plasma lipoprotein particle clearance (GO:0034381) | 2.44091718 |
99 | polyol catabolic process (GO:0046174) | 2.44021359 |
100 | negative regulation of neurotransmitter transport (GO:0051589) | 2.43944027 |
101 | amino-acid betaine metabolic process (GO:0006577) | 2.43571495 |
102 | regulation of cholesterol esterification (GO:0010872) | 2.42711492 |
103 | serine family amino acid catabolic process (GO:0009071) | 2.42693360 |
104 | myofibril assembly (GO:0030239) | 2.42365491 |
105 | opsonization (GO:0008228) | 2.41188727 |
106 | very long-chain fatty acid metabolic process (GO:0000038) | 2.41102933 |
107 | neuronal action potential propagation (GO:0019227) | 2.40602070 |
108 | positive regulation of insulin receptor signaling pathway (GO:0046628) | 2.40460236 |
109 | protein prenylation (GO:0018342) | 2.38933735 |
110 | prenylation (GO:0097354) | 2.38933735 |
111 | positive regulation of lipid catabolic process (GO:0050996) | 2.38807520 |
112 | aspartate family amino acid catabolic process (GO:0009068) | 2.37021791 |
113 | fatty acid elongation (GO:0030497) | 2.36829194 |
114 | cellular response to ethanol (GO:0071361) | 2.36397872 |
115 | regulation of memory T cell differentiation (GO:0043380) | 2.36246558 |
116 | indolalkylamine metabolic process (GO:0006586) | 2.34894795 |
117 | amine catabolic process (GO:0009310) | 2.34703870 |
118 | cellular biogenic amine catabolic process (GO:0042402) | 2.34703870 |
119 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.34189270 |
120 | oocyte development (GO:0048599) | 2.33203212 |
121 | monocarboxylic acid catabolic process (GO:0072329) | 2.32866099 |
122 | cytolysis (GO:0019835) | 2.32666178 |
123 | positive regulation of protein autophosphorylation (GO:0031954) | 2.31472223 |
124 | fatty acid oxidation (GO:0019395) | 2.31041868 |
125 | inositol phosphate catabolic process (GO:0071545) | 2.30892777 |
126 | locomotory exploration behavior (GO:0035641) | 2.30647146 |
127 | glutamate secretion (GO:0014047) | 2.30233487 |
128 | organic acid catabolic process (GO:0016054) | 2.29626125 |
129 | carboxylic acid catabolic process (GO:0046395) | 2.29626125 |
130 | fatty acid catabolic process (GO:0009062) | 2.28635765 |
131 | lipid oxidation (GO:0034440) | 2.28204282 |
132 | gamma-aminobutyric acid transport (GO:0015812) | 2.28180846 |
133 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.28140076 |
134 | fatty acid beta-oxidation (GO:0006635) | 2.27996836 |
135 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.27842147 |
136 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.26871079 |
137 | drug catabolic process (GO:0042737) | 2.26648528 |
138 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic proc | 2.26511285 |
139 | positive regulation of fatty acid oxidation (GO:0046321) | 2.26264914 |
140 | bile acid and bile salt transport (GO:0015721) | 2.26239037 |
141 | fatty acid transmembrane transport (GO:1902001) | 2.26107716 |
142 | negative regulation of complement activation (GO:0045916) | 2.24666126 |
143 | regulation of sequestering of triglyceride (GO:0010889) | 2.24128166 |
144 | regulation of cholesterol homeostasis (GO:2000188) | 2.24108671 |
145 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.23730548 |
146 | regulation of meiosis I (GO:0060631) | 2.23001214 |
147 | interkinetic nuclear migration (GO:0022027) | 2.22108693 |
148 | phospholipid homeostasis (GO:0055091) | 2.21732758 |
149 | relaxation of muscle (GO:0090075) | 2.20630107 |
150 | fibrinolysis (GO:0042730) | 2.20431660 |
151 | negative regulation of alpha-beta T cell differentiation (GO:0046639) | 2.20213125 |
152 | drug transmembrane transport (GO:0006855) | 2.19804467 |
153 | valine metabolic process (GO:0006573) | 2.19700312 |
154 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.19319464 |
155 | 2-oxoglutarate metabolic process (GO:0006103) | 2.19153489 |
156 | acyl-CoA biosynthetic process (GO:0071616) | 2.19051476 |
157 | thioester biosynthetic process (GO:0035384) | 2.19051476 |
158 | parental behavior (GO:0060746) | 2.18912949 |
159 | transcytosis (GO:0045056) | 2.18342512 |
160 | ethanol oxidation (GO:0006069) | 2.18304218 |
161 | inositol phosphate dephosphorylation (GO:0046855) | 2.18227798 |
162 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 2.18227798 |
163 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.16855858 |
164 | kidney morphogenesis (GO:0060993) | 2.15814740 |
165 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 2.15553430 |
166 | magnesium ion transport (GO:0015693) | 2.11806854 |
167 | adenosine metabolic process (GO:0046085) | 2.10018207 |
168 | intestinal epithelial cell development (GO:0060576) | 2.10017763 |
169 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.07812913 |
170 | dentate gyrus development (GO:0021542) | 2.07600680 |
171 | negative regulation of heart rate (GO:0010459) | 2.07431452 |
172 | positive regulation of respiratory burst (GO:0060267) | 2.06681856 |
173 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.06418603 |
174 | regulation of sarcomere organization (GO:0060297) | 2.06241934 |
175 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.04748860 |
176 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.04727014 |
177 | xenobiotic catabolic process (GO:0042178) | 2.04193162 |
178 | growth hormone receptor signaling pathway (GO:0060396) | 2.03435435 |
179 | negative regulation of humoral immune response (GO:0002921) | 2.01660772 |
180 | detection of calcium ion (GO:0005513) | 2.01385899 |
181 | regulation of glycolytic process (GO:0006110) | 2.01362774 |
182 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 1.99527289 |
183 | positive regulation of muscle hypertrophy (GO:0014742) | 1.99235876 |
184 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 1.99235876 |
185 | positive regulation of glycogen biosynthetic process (GO:0045725) | 1.99137604 |
186 | negative regulation of gluconeogenesis (GO:0045721) | 1.99048680 |
187 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 1.98647460 |
188 | microglial cell activation (GO:0001774) | 1.97684180 |
189 | endocrine pancreas development (GO:0031018) | 1.97291053 |
190 | endothelium development (GO:0003158) | 1.96717267 |
191 | negative regulation of cAMP-mediated signaling (GO:0043951) | 1.96698549 |
192 | negative regulation of blood circulation (GO:1903523) | 1.96570151 |
193 | cornea development in camera-type eye (GO:0061303) | 1.95899777 |
194 | protein localization to cilium (GO:0061512) | 1.95679093 |
195 | regulation of membrane repolarization (GO:0060306) | 1.95669853 |
196 | regulation of regulatory T cell differentiation (GO:0045589) | 1.94679250 |
197 | insulin secretion (GO:0030073) | 1.94511155 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.63600224 |
2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.69445821 |
3 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.55262548 |
4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.46351792 |
5 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.34451988 |
6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.23395193 |
7 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.08817653 |
8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.07705219 |
9 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.04295890 |
10 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.03617953 |
11 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.03185654 |
12 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.00222538 |
13 | * FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.99595276 |
14 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.89933765 |
15 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.79045653 |
16 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.77782782 |
17 | FUS_26573619_Chip-Seq_HEK293_Human | 1.76473662 |
18 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.76399282 |
19 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.76267383 |
20 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.74383620 |
21 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.73691757 |
22 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.73568737 |
23 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.72855431 |
24 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.69534644 |
25 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.69497741 |
26 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.69497741 |
27 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.67563027 |
28 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.65842430 |
29 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.60616747 |
30 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.60388020 |
31 | * SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.60089743 |
32 | * PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.60081064 |
33 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.59576332 |
34 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.57627659 |
35 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.55046579 |
36 | EWS_26573619_Chip-Seq_HEK293_Human | 1.45270825 |
37 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.45090118 |
38 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.45003440 |
39 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.44106498 |
40 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.43642145 |
41 | P300_19829295_ChIP-Seq_ESCs_Human | 1.43363009 |
42 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.42550357 |
43 | * NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.42429576 |
44 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.41254187 |
45 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.41088905 |
46 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.40978907 |
47 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.38755487 |
48 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 1.38597956 |
49 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.38550778 |
50 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.38169794 |
51 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.38169794 |
52 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.37235210 |
53 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.36959337 |
54 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.36703007 |
55 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.35928035 |
56 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.35679526 |
57 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.34816207 |
58 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.34283069 |
59 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.31607834 |
60 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.30535620 |
61 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.30212538 |
62 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.30131304 |
63 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.29532131 |
64 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.29532131 |
65 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.28997699 |
66 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.27069525 |
67 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.26529691 |
68 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.26355628 |
69 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.24730360 |
70 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.23993791 |
71 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.23190846 |
72 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.22902084 |
73 | * OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.22808902 |
74 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.22273142 |
75 | * CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.22054813 |
76 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.21741406 |
77 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.21121482 |
78 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.21011167 |
79 | AR_25329375_ChIP-Seq_VCAP_Human | 1.20769560 |
80 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.20372782 |
81 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.20273608 |
82 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.19899980 |
83 | * SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.19600393 |
84 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.18886722 |
85 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.18230465 |
86 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.17456789 |
87 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.16803169 |
88 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.16591054 |
89 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.16310318 |
90 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.16310318 |
91 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.16309943 |
92 | TP53_16413492_ChIP-PET_HCT116_Human | 1.16150261 |
93 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.16141892 |
94 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.15908898 |
95 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.15729010 |
96 | * SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.15704831 |
97 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.14582688 |
98 | * STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.13213866 |
99 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.12320821 |
100 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.12111191 |
101 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.11751787 |
102 | * EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.11590426 |
103 | STAT3_23295773_ChIP-Seq_U87_Human | 1.10879916 |
104 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.10429569 |
105 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.09790292 |
106 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.09045390 |
107 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.08502318 |
108 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.08203646 |
109 | * P300_18555785_Chip-Seq_ESCs_Mouse | 1.08057235 |
110 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.07422057 |
111 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.07383963 |
112 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.07238776 |
113 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.06592658 |
114 | * OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.05745491 |
115 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.05532943 |
116 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.05127587 |
117 | * SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.04998711 |
118 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.04704529 |
119 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.03081570 |
120 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.02173375 |
121 | RXR_22108803_ChIP-Seq_LS180_Human | 1.00681586 |
122 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.00535604 |
123 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.99263090 |
124 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.97019379 |
125 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.96577564 |
126 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.95614899 |
127 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.95461050 |
128 | VDR_22108803_ChIP-Seq_LS180_Human | 0.94904550 |
129 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.93306388 |
130 | GATA1_22025678_ChIP-Seq_K562_Human | 0.92766707 |
131 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.91479920 |
132 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.91389708 |
133 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.91190830 |
134 | * TCF4_23295773_ChIP-Seq_U87_Human | 0.91118727 |
135 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.91067284 |
136 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 0.89524764 |
137 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.88256124 |
138 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.88117006 |
139 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.87707293 |
140 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.87657780 |
141 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.86541426 |
142 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.86158000 |
143 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.85990952 |
144 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.84711548 |
145 | AR_19668381_ChIP-Seq_PC3_Human | 0.83053948 |
146 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.82971578 |
147 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.82688135 |
148 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.82581805 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 4.77871014 |
2 | MP0005085_abnormal_gallbladder_physiolo | 4.21623950 |
3 | MP0005360_urolithiasis | 4.12642637 |
4 | MP0003787_abnormal_imprinting | 3.87139222 |
5 | MP0005365_abnormal_bile_salt | 3.86902660 |
6 | MP0000569_abnormal_digit_pigmentation | 3.36240025 |
7 | MP0008875_abnormal_xenobiotic_pharmacok | 3.06043253 |
8 | MP0003724_increased_susceptibility_to | 2.89161192 |
9 | MP0004859_abnormal_synaptic_plasticity | 2.70654047 |
10 | MP0006054_spinal_hemorrhage | 2.61687692 |
11 | MP0003646_muscle_fatigue | 2.57714406 |
12 | MP0008877_abnormal_DNA_methylation | 2.57540982 |
13 | MP0003252_abnormal_bile_duct | 2.40513674 |
14 | MP0003880_abnormal_central_pattern | 2.38638386 |
15 | MP0010329_abnormal_lipoprotein_level | 2.36954705 |
16 | MP0002638_abnormal_pupillary_reflex | 2.36313331 |
17 | MP0003195_calcinosis | 2.31028236 |
18 | MP0004484_altered_response_of | 2.25064499 |
19 | MP0002822_catalepsy | 2.19313496 |
20 | MP0004215_abnormal_myocardial_fiber | 2.09558627 |
21 | MP0005083_abnormal_biliary_tract | 2.07741562 |
22 | MP0004270_analgesia | 2.06786968 |
23 | MP0001666_abnormal_nutrient_absorption | 2.03547541 |
24 | MP0004036_abnormal_muscle_relaxation | 2.00441662 |
25 | MP0003635_abnormal_synaptic_transmissio | 1.97667651 |
26 | MP0005332_abnormal_amino_acid | 1.91565768 |
27 | MP0004084_abnormal_cardiac_muscle | 1.88399027 |
28 | MP0010234_abnormal_vibrissa_follicle | 1.86857692 |
29 | MP0009745_abnormal_behavioral_response | 1.82723760 |
30 | MP0002118_abnormal_lipid_homeostasis | 1.73331647 |
31 | MP0009780_abnormal_chondrocyte_physiolo | 1.72977236 |
32 | MP0003690_abnormal_glial_cell | 1.70115234 |
33 | MP0002837_dystrophic_cardiac_calcinosis | 1.69428544 |
34 | MP0002064_seizures | 1.67720032 |
35 | MP0003329_amyloid_beta_deposits | 1.67662827 |
36 | MP0005620_abnormal_muscle_contractility | 1.67343352 |
37 | MP0004130_abnormal_muscle_cell | 1.67063419 |
38 | MP0002009_preneoplasia | 1.66474764 |
39 | MP0005464_abnormal_platelet_physiology | 1.65254913 |
40 | MP0003806_abnormal_nucleotide_metabolis | 1.60175857 |
41 | MP0003868_abnormal_feces_composition | 1.60092280 |
42 | MP0002063_abnormal_learning/memory/cond | 1.54307359 |
43 | MP0001501_abnormal_sleep_pattern | 1.54097260 |
44 | MP0002254_reproductive_system_inflammat | 1.53459667 |
45 | MP0000427_abnormal_hair_cycle | 1.52871903 |
46 | MP0002166_altered_tumor_susceptibility | 1.49185809 |
47 | MP0000383_abnormal_hair_follicle | 1.48866041 |
48 | MP0001486_abnormal_startle_reflex | 1.45873726 |
49 | MP0009046_muscle_twitch | 1.43673628 |
50 | MP0000013_abnormal_adipose_tissue | 1.39780888 |
51 | MP0008004_abnormal_stomach_pH | 1.39770819 |
52 | MP0002272_abnormal_nervous_system | 1.38944178 |
53 | MP0003191_abnormal_cellular_cholesterol | 1.37655449 |
54 | MP0003656_abnormal_erythrocyte_physiolo | 1.35613915 |
55 | MP0002572_abnormal_emotion/affect_behav | 1.34313404 |
56 | MP0005645_abnormal_hypothalamus_physiol | 1.32557292 |
57 | MP0002876_abnormal_thyroid_physiology | 1.30917101 |
58 | MP0005646_abnormal_pituitary_gland | 1.30293729 |
59 | MP0008775_abnormal_heart_ventricle | 1.30070355 |
60 | MP0000465_gastrointestinal_hemorrhage | 1.29798854 |
61 | MP0003045_fibrosis | 1.29368609 |
62 | MP0002972_abnormal_cardiac_muscle | 1.27186698 |
63 | MP0005535_abnormal_body_temperature | 1.26648215 |
64 | MP0001968_abnormal_touch/_nociception | 1.26537633 |
65 | MP0003011_delayed_dark_adaptation | 1.26219183 |
66 | MP0000920_abnormal_myelination | 1.25652169 |
67 | MP0001756_abnormal_urination | 1.25408167 |
68 | MP0002909_abnormal_adrenal_gland | 1.24943531 |
69 | MP0000749_muscle_degeneration | 1.23319849 |
70 | MP0000604_amyloidosis | 1.22585911 |
71 | MP0002102_abnormal_ear_morphology | 1.22272305 |
72 | MP0004885_abnormal_endolymph | 1.19829986 |
73 | MP0003121_genomic_imprinting | 1.19675306 |
74 | MP0004510_myositis | 1.18344047 |
75 | MP0004019_abnormal_vitamin_homeostasis | 1.17196854 |
76 | MP0003633_abnormal_nervous_system | 1.16856472 |
77 | MP0002106_abnormal_muscle_physiology | 1.14340269 |
78 | MP0001440_abnormal_grooming_behavior | 1.13344215 |
79 | MP0002163_abnormal_gland_morphology | 1.10782929 |
80 | MP0006276_abnormal_autonomic_nervous | 1.10082732 |
81 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.09995200 |
82 | MP0002693_abnormal_pancreas_physiology | 1.09797448 |
83 | MP0000372_irregular_coat_pigmentation | 1.09527719 |
84 | MP0005174_abnormal_tail_pigmentation | 1.08861495 |
85 | MP0005253_abnormal_eye_physiology | 1.08659857 |
86 | MP0002067_abnormal_sensory_capabilities | 1.04708601 |
87 | MP0005369_muscle_phenotype | 1.02703853 |
88 | MP0000609_abnormal_liver_physiology | 1.02071309 |
89 | MP0004085_abnormal_heartbeat | 1.01937739 |
90 | MP0002734_abnormal_mechanical_nocicepti | 1.01121413 |
91 | MP0002090_abnormal_vision | 1.00500306 |
92 | MP0004147_increased_porphyrin_level | 0.99836517 |
93 | MP0005187_abnormal_penis_morphology | 0.99581416 |
94 | MP0002078_abnormal_glucose_homeostasis | 0.98218154 |
95 | MP0002796_impaired_skin_barrier | 0.96823499 |
96 | MP0005167_abnormal_blood-brain_barrier | 0.95478226 |
97 | MP0002736_abnormal_nociception_after | 0.95304447 |
98 | MP0004043_abnormal_pH_regulation | 0.95134635 |
99 | MP0002127_abnormal_cardiovascular_syste | 0.94983943 |
100 | MP0004883_abnormal_blood_vessel | 0.94840583 |
101 | MP0008874_decreased_physiological_sensi | 0.94449295 |
102 | MP0002138_abnormal_hepatobiliary_system | 0.92769616 |
103 | MP0010386_abnormal_urinary_bladder | 0.92408427 |
104 | MP0008872_abnormal_physiological_respon | 0.92235373 |
105 | MP0005084_abnormal_gallbladder_morpholo | 0.91485099 |
106 | MP0002277_abnormal_respiratory_mucosa | 0.90764177 |
107 | MP0002332_abnormal_exercise_endurance | 0.90452089 |
108 | MP0005386_behavior/neurological_phenoty | 0.89527556 |
109 | MP0004924_abnormal_behavior | 0.89527556 |
110 | MP0002971_abnormal_brown_adipose | 0.88965789 |
111 | MP0002108_abnormal_muscle_morphology | 0.88860361 |
112 | MP0003631_nervous_system_phenotype | 0.88299180 |
113 | MP0002168_other_aberrant_phenotype | 0.88216083 |
114 | MP0001661_extended_life_span | 0.85980404 |
115 | MP0001502_abnormal_circadian_rhythm | 0.84776473 |
116 | MP0009840_abnormal_foam_cell | 0.84158833 |
117 | MP0003828_pulmonary_edema | 0.83441852 |
118 | MP0010678_abnormal_skin_adnexa | 0.82936884 |
119 | MP0003122_maternal_imprinting | 0.82510800 |
120 | MP0005319_abnormal_enzyme/_coenzyme | 0.81459619 |
121 | MP0005220_abnormal_exocrine_pancreas | 0.81331161 |
122 | MP0008961_abnormal_basal_metabolism | 0.81208427 |
123 | MP0006072_abnormal_retinal_apoptosis | 0.80391011 |
124 | MP0001544_abnormal_cardiovascular_syste | 0.80331850 |
125 | MP0005385_cardiovascular_system_phenoty | 0.80331850 |
126 | MP0005075_abnormal_melanosome_morpholog | 0.80177157 |
127 | MP0001984_abnormal_olfaction | 0.79596067 |
128 | MP0002557_abnormal_social/conspecific_i | 0.79369794 |
129 | MP0002733_abnormal_thermal_nociception | 0.79226631 |
130 | MP0003283_abnormal_digestive_organ | 0.79212469 |
131 | MP0002928_abnormal_bile_duct | 0.79115828 |
132 | MP0001765_abnormal_ion_homeostasis | 0.78600917 |
133 | MP0003137_abnormal_impulse_conducting | 0.78451193 |
134 | MP0010368_abnormal_lymphatic_system | 0.77970889 |
135 | MP0009643_abnormal_urine_homeostasis | 0.76974643 |
136 | MP0002735_abnormal_chemical_nociception | 0.76788290 |
137 | MP0005666_abnormal_adipose_tissue | 0.75966658 |
138 | MP0000778_abnormal_nervous_system | 0.75287238 |
139 | MP0005367_renal/urinary_system_phenotyp | 0.74963906 |
140 | MP0000516_abnormal_urinary_system | 0.74963906 |
141 | MP0005670_abnormal_white_adipose | 0.73854770 |
142 | MP0001970_abnormal_pain_threshold | 0.72600970 |
143 | MP0008569_lethality_at_weaning | 0.72564065 |
144 | MP0005248_abnormal_Harderian_gland | 0.72383124 |
145 | MP0001177_atelectasis | 0.72217835 |
146 | MP0005379_endocrine/exocrine_gland_phen | 0.72091367 |
147 | MP0003183_abnormal_peptide_metabolism | 0.70984065 |
148 | MP0001764_abnormal_homeostasis | 0.69988312 |
149 | MP0000230_abnormal_systemic_arterial | 0.69689956 |
150 | MP0004134_abnormal_chest_morphology | 0.69483638 |
151 | MP0003075_altered_response_to | 0.69458415 |
152 | MP0005334_abnormal_fat_pad | 0.69280168 |
153 | MP0002066_abnormal_motor_capabilities/c | 0.68888190 |
154 | MP0004381_abnormal_hair_follicle | 0.67620761 |
155 | MP0005551_abnormal_eye_electrophysiolog | 0.67503132 |
156 | MP0001944_abnormal_pancreas_morphology | 0.67396071 |
157 | MP0005647_abnormal_sex_gland | 0.67202885 |
158 | MP0002229_neurodegeneration | 0.67093651 |
159 | MP0004142_abnormal_muscle_tone | 0.66958824 |
160 | MP0002069_abnormal_eating/drinking_beha | 0.66609359 |
161 | MP0003632_abnormal_nervous_system | 0.66507266 |
162 | MP0004145_abnormal_muscle_electrophysio | 0.65081946 |
163 | MP0004185_abnormal_adipocyte_glucose | 0.65022467 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.83955220 |
2 | Intrahepatic cholestasis (HP:0001406) | 4.76101625 |
3 | Deep venous thrombosis (HP:0002625) | 4.56119548 |
4 | Xanthomatosis (HP:0000991) | 4.33333955 |
5 | Prolonged partial thromboplastin time (HP:0003645) | 4.27974427 |
6 | Hyperlipoproteinemia (HP:0010980) | 4.22614323 |
7 | Complement deficiency (HP:0004431) | 3.86622921 |
8 | Ketosis (HP:0001946) | 3.78207587 |
9 | Focal motor seizures (HP:0011153) | 3.74927303 |
10 | Muscle fiber inclusion bodies (HP:0100299) | 3.74838589 |
11 | Nemaline bodies (HP:0003798) | 3.69459851 |
12 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.54612148 |
13 | Hypothermia (HP:0002045) | 3.52679580 |
14 | Ketoacidosis (HP:0001993) | 3.44026301 |
15 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.40149135 |
16 | Hypoglycemic coma (HP:0001325) | 3.39255684 |
17 | Hyperglycinemia (HP:0002154) | 3.38815681 |
18 | Calf muscle hypertrophy (HP:0008981) | 3.38784050 |
19 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.37654749 |
20 | Hyperventilation (HP:0002883) | 3.33837400 |
21 | Epidermoid cyst (HP:0200040) | 3.16087108 |
22 | Hematochezia (HP:0002573) | 3.14498785 |
23 | Neurofibrillary tangles (HP:0002185) | 3.12819023 |
24 | Papillary thyroid carcinoma (HP:0002895) | 3.10274532 |
25 | Hypobetalipoproteinemia (HP:0003563) | 3.01932728 |
26 | Abnormality of the common coagulation pathway (HP:0010990) | 3.00291702 |
27 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.99491802 |
28 | Abnormality of glycine metabolism (HP:0010895) | 2.99491802 |
29 | Abnormality of the renal cortex (HP:0011035) | 2.96131120 |
30 | Hypoalphalipoproteinemia (HP:0003233) | 2.93558456 |
31 | Thyroiditis (HP:0100646) | 2.91591275 |
32 | Hyperammonemia (HP:0001987) | 2.90637420 |
33 | Prolonged bleeding time (HP:0003010) | 2.89020882 |
34 | Hyperglycinuria (HP:0003108) | 2.88121791 |
35 | Metaphyseal dysplasia (HP:0100255) | 2.82375652 |
36 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.76986438 |
37 | Hypolipoproteinemia (HP:0010981) | 2.73454748 |
38 | Fat malabsorption (HP:0002630) | 2.69878489 |
39 | Cerebral inclusion bodies (HP:0100314) | 2.68740377 |
40 | Hypoglycemic seizures (HP:0002173) | 2.68290800 |
41 | Conjugated hyperbilirubinemia (HP:0002908) | 2.65610995 |
42 | Renal cortical cysts (HP:0000803) | 2.64261713 |
43 | Atonic seizures (HP:0010819) | 2.56795444 |
44 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.56638412 |
45 | Thyroid carcinoma (HP:0002890) | 2.56233247 |
46 | Focal seizures (HP:0007359) | 2.56135869 |
47 | Difficulty running (HP:0009046) | 2.55662103 |
48 | Hyporeflexia of lower limbs (HP:0002600) | 2.55373746 |
49 | Joint hemorrhage (HP:0005261) | 2.54608194 |
50 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.53825289 |
51 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.47457780 |
52 | Abnormality of methionine metabolism (HP:0010901) | 2.47095614 |
53 | Abnormality of the intrinsic pathway (HP:0010989) | 2.44686858 |
54 | Action tremor (HP:0002345) | 2.43819814 |
55 | Status epilepticus (HP:0002133) | 2.43714886 |
56 | Myokymia (HP:0002411) | 2.40762942 |
57 | Abnormality of complement system (HP:0005339) | 2.38802280 |
58 | Medial flaring of the eyebrow (HP:0010747) | 2.35801564 |
59 | Exercise-induced muscle cramps (HP:0003710) | 2.35059375 |
60 | Delayed CNS myelination (HP:0002188) | 2.35045205 |
61 | Intention tremor (HP:0002080) | 2.34534828 |
62 | Gingival bleeding (HP:0000225) | 2.33477501 |
63 | Abnormality of the calf musculature (HP:0001430) | 2.33135086 |
64 | Ventricular fibrillation (HP:0001663) | 2.32815501 |
65 | Abnormality of secondary sexual hair (HP:0009888) | 2.31657427 |
66 | Abnormality of the axillary hair (HP:0100134) | 2.31657427 |
67 | Scanning speech (HP:0002168) | 2.30916976 |
68 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.29957981 |
69 | Gaze-evoked nystagmus (HP:0000640) | 2.28914659 |
70 | Amyloidosis (HP:0011034) | 2.27388540 |
71 | Generalized tonic-clonic seizures (HP:0002069) | 2.24875951 |
72 | Skin nodule (HP:0200036) | 2.24288112 |
73 | Type 1 muscle fiber predominance (HP:0003803) | 2.21200389 |
74 | Abnormal biliary tract morphology (HP:0012440) | 2.20761733 |
75 | Mitral stenosis (HP:0001718) | 2.20149878 |
76 | Biliary tract neoplasm (HP:0100574) | 2.16904430 |
77 | Absence seizures (HP:0002121) | 2.16276203 |
78 | Epileptic encephalopathy (HP:0200134) | 2.15957889 |
79 | Conjunctival hamartoma (HP:0100780) | 2.14299064 |
80 | Hyperglycemia (HP:0003074) | 2.11703731 |
81 | Distal arthrogryposis (HP:0005684) | 2.11662296 |
82 | Hypomagnesemia (HP:0002917) | 2.11549833 |
83 | Stomatitis (HP:0010280) | 2.08894776 |
84 | Spontaneous hematomas (HP:0007420) | 2.07801239 |
85 | Hypercholesterolemia (HP:0003124) | 2.07289834 |
86 | Bundle branch block (HP:0011710) | 2.07190329 |
87 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.06504053 |
88 | Pancreatic cysts (HP:0001737) | 2.04573462 |
89 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.04276150 |
90 | Gout (HP:0001997) | 2.02315385 |
91 | Subaortic stenosis (HP:0001682) | 2.02154883 |
92 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.02154883 |
93 | Cerebral hemorrhage (HP:0001342) | 2.02083520 |
94 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.01460490 |
95 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.01460490 |
96 | Dysmetria (HP:0001310) | 2.01360402 |
97 | Abnormality of purine metabolism (HP:0004352) | 1.99699058 |
98 | Steatorrhea (HP:0002570) | 1.98645217 |
99 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.97357588 |
100 | Dialeptic seizures (HP:0011146) | 1.97326084 |
101 | Hamartoma of the eye (HP:0010568) | 1.97247119 |
102 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.96795233 |
103 | Hypoplasia of the fovea (HP:0007750) | 1.96795233 |
104 | Spontaneous abortion (HP:0005268) | 1.96066566 |
105 | Sensorimotor neuropathy (HP:0007141) | 1.95763919 |
106 | Facial diplegia (HP:0001349) | 1.95657554 |
107 | Rimmed vacuoles (HP:0003805) | 1.95292640 |
108 | Curly hair (HP:0002212) | 1.95019336 |
109 | Symptomatic seizures (HP:0011145) | 1.94411737 |
110 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 1.94122325 |
111 | Progressive cerebellar ataxia (HP:0002073) | 1.93429369 |
112 | Testicular neoplasm (HP:0010788) | 1.92744661 |
113 | Poikilocytosis (HP:0004447) | 1.92331472 |
114 | Widely spaced teeth (HP:0000687) | 1.92318526 |
115 | Muscle fiber splitting (HP:0003555) | 1.92127405 |
116 | Dysdiadochokinesis (HP:0002075) | 1.91975528 |
117 | Anxiety (HP:0000739) | 1.91160313 |
118 | Methylmalonic acidemia (HP:0002912) | 1.91080422 |
119 | Confusion (HP:0001289) | 1.90898395 |
120 | Blue irides (HP:0000635) | 1.90545848 |
121 | Fair hair (HP:0002286) | 1.90534878 |
122 | Abnormal pancreas size (HP:0012094) | 1.90278759 |
123 | Exercise-induced myalgia (HP:0003738) | 1.90171553 |
124 | Metabolic alkalosis (HP:0200114) | 1.89836383 |
125 | Abnormality of the renal medulla (HP:0100957) | 1.89228041 |
126 | Myocardial infarction (HP:0001658) | 1.88161990 |
127 | Vascular calcification (HP:0004934) | 1.88131109 |
128 | Abnormal drinking behavior (HP:0030082) | 1.87880702 |
129 | Polydipsia (HP:0001959) | 1.87880702 |
130 | Abnormality of serum amino acid levels (HP:0003112) | 1.87256400 |
131 | Metabolic acidosis (HP:0001942) | 1.86941096 |
132 | Visual hallucinations (HP:0002367) | 1.86391939 |
133 | Abnormal social behavior (HP:0012433) | 1.85709001 |
134 | Impaired social interactions (HP:0000735) | 1.85709001 |
135 | Generalized hypopigmentation of hair (HP:0011358) | 1.85618935 |
136 | Increased mean platelet volume (HP:0011877) | 1.85277287 |
137 | Febrile seizures (HP:0002373) | 1.84459547 |
138 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.83686247 |
139 | Hypochromic microcytic anemia (HP:0004840) | 1.83617510 |
140 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.83270924 |
141 | Stomach cancer (HP:0012126) | 1.82587094 |
142 | Pancreatic fibrosis (HP:0100732) | 1.82285709 |
143 | Papilledema (HP:0001085) | 1.81008657 |
144 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.79988124 |
145 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.79988124 |
146 | Abnormality of the corticospinal tract (HP:0002492) | 1.79455539 |
147 | Disproportionate short-trunk short stature (HP:0003521) | 1.79205008 |
148 | Abnormality of the fovea (HP:0000493) | 1.78913064 |
149 | Abnormality of T cell number (HP:0011839) | 1.78497224 |
150 | Drooling (HP:0002307) | 1.75404865 |
151 | Excessive salivation (HP:0003781) | 1.75404865 |
152 | Abnormality of potassium homeostasis (HP:0011042) | 1.75303453 |
153 | Epileptiform EEG discharges (HP:0011182) | 1.75053189 |
154 | Abolished electroretinogram (ERG) (HP:0000550) | 1.74988313 |
155 | Decreased circulating renin level (HP:0003351) | 1.74111050 |
156 | Frequent falls (HP:0002359) | 1.74011128 |
157 | Hypokalemia (HP:0002900) | 1.73542545 |
158 | Spastic gait (HP:0002064) | 1.73132096 |
159 | Irritability (HP:0000737) | 1.72712773 |
160 | Hypophosphatemic rickets (HP:0004912) | 1.72694286 |
161 | Areflexia of lower limbs (HP:0002522) | 1.72361615 |
162 | Hyperbilirubinemia (HP:0002904) | 1.71756069 |
163 | Abnormality of vitamin B metabolism (HP:0004340) | 1.71384744 |
164 | Pancreatitis (HP:0001733) | 1.71293855 |
165 | Poor eye contact (HP:0000817) | 1.71007676 |
166 | Arthropathy (HP:0003040) | 1.70824283 |
167 | T lymphocytopenia (HP:0005403) | 1.70402459 |
168 | Nephronophthisis (HP:0000090) | 1.69912278 |
169 | Cardiovascular calcification (HP:0011915) | 1.69561957 |
170 | Epistaxis (HP:0000421) | 1.68926112 |
171 | EEG with generalized epileptiform discharges (HP:0011198) | 1.68701488 |
172 | Abnormal gallbladder morphology (HP:0012437) | 1.66953340 |
173 | Cerebral edema (HP:0002181) | 1.66720341 |
174 | Increased circulating renin level (HP:0000848) | 1.66522251 |
175 | Hyperkalemia (HP:0002153) | 1.65904988 |
176 | Syncope (HP:0001279) | 1.65336775 |
177 | Abnormal platelet volume (HP:0011876) | 1.65251999 |
178 | Acanthocytosis (HP:0001927) | 1.65081064 |
179 | Termporal pattern (HP:0011008) | 1.64598055 |
180 | Insidious onset (HP:0003587) | 1.64598055 |
181 | Enlarged penis (HP:0000040) | 1.62106990 |
182 | EMG: myopathic abnormalities (HP:0003458) | 1.61862207 |
183 | Proximal tubulopathy (HP:0000114) | 1.60278986 |
184 | Long clavicles (HP:0000890) | 1.60221442 |
185 | Increased CSF protein (HP:0002922) | 1.59289451 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EPHA4 | 3.46783565 |
2 | OBSCN | 3.45410266 |
3 | NTRK3 | 2.79484203 |
4 | INSRR | 2.76198967 |
5 | STK24 | 2.47802250 |
6 | MAP2K4 | 2.43618041 |
7 | ACVR1B | 2.38676624 |
8 | BCKDK | 2.35572791 |
9 | MAP3K4 | 2.06517411 |
10 | BMPR1B | 2.03389124 |
11 | CASK | 1.98942397 |
12 | ERBB3 | 1.86168602 |
13 | DAPK2 | 1.84052512 |
14 | FRK | 1.82998898 |
15 | FGFR2 | 1.76484499 |
16 | STK39 | 1.75491511 |
17 | MST4 | 1.74938812 |
18 | MAP4K2 | 1.74777901 |
19 | MAP2K7 | 1.71066595 |
20 | NLK | 1.67392102 |
21 | OXSR1 | 1.65602526 |
22 | NTRK1 | 1.60530432 |
23 | MAP3K2 | 1.54139850 |
24 | NUAK1 | 1.53926587 |
25 | PNCK | 1.51087469 |
26 | NTRK2 | 1.50261418 |
27 | SIK1 | 1.42052840 |
28 | WNK3 | 1.41037216 |
29 | FGFR3 | 1.38531624 |
30 | STK3 | 1.38116192 |
31 | MAPK15 | 1.36415315 |
32 | PLK2 | 1.35641461 |
33 | TRPM7 | 1.30380415 |
34 | MAP3K9 | 1.29430150 |
35 | FER | 1.24922974 |
36 | SGK223 | 1.22129435 |
37 | SGK494 | 1.22129435 |
38 | RIPK4 | 1.19617800 |
39 | TEC | 1.18471932 |
40 | CAMK1G | 1.15573497 |
41 | MAP3K12 | 1.14747237 |
42 | TXK | 1.11755182 |
43 | MAP3K13 | 1.10594882 |
44 | PAK3 | 1.09894177 |
45 | PAK6 | 1.08734605 |
46 | MAP3K7 | 1.06814408 |
47 | TNIK | 1.06810542 |
48 | KSR2 | 1.06749588 |
49 | RET | 1.05622425 |
50 | PIK3CA | 1.05247129 |
51 | EPHA3 | 1.03457081 |
52 | MAPK13 | 1.02913687 |
53 | CDK5 | 1.02563259 |
54 | SGK2 | 1.01289837 |
55 | IRAK1 | 1.00357157 |
56 | TAOK3 | 0.98060711 |
57 | MARK1 | 0.97110791 |
58 | MINK1 | 0.95910194 |
59 | WNK4 | 0.95795694 |
60 | ADRBK2 | 0.94123560 |
61 | GRK5 | 0.92792449 |
62 | FGFR4 | 0.92238754 |
63 | CAMKK2 | 0.91920159 |
64 | NEK6 | 0.91243143 |
65 | STK38L | 0.90986986 |
66 | PRKCH | 0.89735554 |
67 | SIK2 | 0.89291889 |
68 | MAPK12 | 0.88795073 |
69 | PHKG1 | 0.88345520 |
70 | PHKG2 | 0.88345520 |
71 | CAMK2A | 0.88035723 |
72 | PKN1 | 0.87393331 |
73 | SGK3 | 0.86633493 |
74 | AKT3 | 0.86396357 |
75 | YES1 | 0.86371453 |
76 | MYLK | 0.86168772 |
77 | WNK1 | 0.85772474 |
78 | PDPK1 | 0.81670191 |
79 | PINK1 | 0.81432545 |
80 | STK11 | 0.81315975 |
81 | PRKCE | 0.80565631 |
82 | CAMK2B | 0.80531979 |
83 | CAMKK1 | 0.80402172 |
84 | MARK3 | 0.79816321 |
85 | JAK1 | 0.78414295 |
86 | PIK3CG | 0.78409735 |
87 | BRSK2 | 0.76725811 |
88 | BMPR2 | 0.75870162 |
89 | PTK6 | 0.75808858 |
90 | MUSK | 0.74576161 |
91 | MAP2K1 | 0.74475300 |
92 | CSNK1G2 | 0.74130122 |
93 | BCR | 0.73809749 |
94 | FES | 0.73397359 |
95 | MST1R | 0.72925663 |
96 | PRKCQ | 0.72789849 |
97 | PRKAA2 | 0.72418301 |
98 | CAMK2D | 0.71455702 |
99 | SGK1 | 0.71427937 |
100 | MAP3K1 | 0.70668870 |
101 | PDK1 | 0.70035118 |
102 | PRKCG | 0.69726373 |
103 | PRKD3 | 0.67756901 |
104 | PDK2 | 0.67118297 |
105 | FGR | 0.66561688 |
106 | GRK7 | 0.66256938 |
107 | TIE1 | 0.65653766 |
108 | LATS1 | 0.65620234 |
109 | ADRBK1 | 0.64731582 |
110 | ERBB4 | 0.64033442 |
111 | CAMK2G | 0.63803677 |
112 | STK38 | 0.63626903 |
113 | PTK2B | 0.63387777 |
114 | ITK | 0.63339957 |
115 | SYK | 0.63073334 |
116 | MET | 0.62773847 |
117 | MAPK7 | 0.61553685 |
118 | PRKCZ | 0.60802775 |
119 | BTK | 0.60170000 |
120 | TYRO3 | 0.60048716 |
121 | KIT | 0.58684480 |
122 | TRIM28 | 0.57374089 |
123 | GRK1 | 0.55956020 |
124 | KSR1 | 0.55495470 |
125 | CSNK1G1 | 0.54228702 |
126 | CAMK1D | 0.54057502 |
127 | EPHB1 | 0.53459373 |
128 | PRKD1 | 0.52877838 |
129 | ERBB2 | 0.52768813 |
130 | HIPK2 | 0.52416884 |
131 | CSK | 0.51754949 |
132 | PDGFRA | 0.49877077 |
133 | TGFBR1 | 0.49826441 |
134 | TNK2 | 0.49674902 |
135 | MAP2K6 | 0.49615408 |
136 | PRKG1 | 0.49336148 |
137 | MARK2 | 0.48587999 |
138 | GSK3A | 0.48183157 |
139 | CAMK1 | 0.48117838 |
140 | TGFBR2 | 0.48059845 |
141 | GRK6 | 0.47670870 |
142 | HCK | 0.47430332 |
143 | MAPKAPK3 | 0.46999838 |
144 | PRKACG | 0.46907316 |
145 | PRKAA1 | 0.45792299 |
146 | IKBKE | 0.45737479 |
147 | NEK9 | 0.45400844 |
148 | BLK | 0.44425469 |
149 | IKBKB | 0.43305381 |
150 | DMPK | 0.43109534 |
151 | DYRK1A | 0.41472165 |
152 | MAP3K6 | 0.40559279 |
153 | LYN | 0.39808917 |
154 | TYK2 | 0.39207299 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.40274767 |
2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.18008974 |
3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.41765779 |
4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.36869950 |
5 | Circadian rhythm_Homo sapiens_hsa04710 | 2.25841178 |
6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.10981007 |
7 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.03051796 |
8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.02495276 |
9 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.94086544 |
10 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.89102987 |
11 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.85894502 |
12 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.79897017 |
13 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.74906966 |
14 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.72066099 |
15 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.66993933 |
16 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.62101697 |
17 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.60080026 |
18 | Platelet activation_Homo sapiens_hsa04611 | 1.56507792 |
19 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.55078564 |
20 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.53749659 |
21 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.51502509 |
22 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.48735551 |
23 | Peroxisome_Homo sapiens_hsa04146 | 1.44047309 |
24 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.43806823 |
25 | Bile secretion_Homo sapiens_hsa04976 | 1.43452409 |
26 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.39494445 |
27 | Histidine metabolism_Homo sapiens_hsa00340 | 1.38018855 |
28 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.36677308 |
29 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.36126867 |
30 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.35912516 |
31 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.33448139 |
32 | Nicotine addiction_Homo sapiens_hsa05033 | 1.33138232 |
33 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.32448302 |
34 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.31573731 |
35 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.30230586 |
36 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.26567777 |
37 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.23603537 |
38 | GABAergic synapse_Homo sapiens_hsa04727 | 1.18303323 |
39 | Phototransduction_Homo sapiens_hsa04744 | 1.13875849 |
40 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.12531860 |
41 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.09967205 |
42 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.09820485 |
43 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.09436668 |
44 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.08454445 |
45 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.08227830 |
46 | ABC transporters_Homo sapiens_hsa02010 | 1.08158821 |
47 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.06606133 |
48 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.06521972 |
49 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.05183635 |
50 | Retinol metabolism_Homo sapiens_hsa00830 | 1.03202868 |
51 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.03077111 |
52 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.01682579 |
53 | Renin secretion_Homo sapiens_hsa04924 | 1.00333868 |
54 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.99869254 |
55 | Circadian entrainment_Homo sapiens_hsa04713 | 0.97872935 |
56 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.97375409 |
57 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.96850913 |
58 | Insulin secretion_Homo sapiens_hsa04911 | 0.94245552 |
59 | Salivary secretion_Homo sapiens_hsa04970 | 0.94152152 |
60 | Long-term potentiation_Homo sapiens_hsa04720 | 0.94047002 |
61 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.93145868 |
62 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.91370565 |
63 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.91105774 |
64 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.90325109 |
65 | Morphine addiction_Homo sapiens_hsa05032 | 0.89850768 |
66 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.89415251 |
67 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.88490064 |
68 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.87890869 |
69 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.86761963 |
70 | Taste transduction_Homo sapiens_hsa04742 | 0.84952116 |
71 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.83124579 |
72 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.82990105 |
73 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.82783935 |
74 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.80213706 |
75 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.79615659 |
76 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.79581175 |
77 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.77307930 |
78 | Protein export_Homo sapiens_hsa03060 | 0.76056730 |
79 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.74904501 |
80 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.74658888 |
81 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.73901315 |
82 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.72547696 |
83 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.72508397 |
84 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.71244576 |
85 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.70883969 |
86 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.70496075 |
87 | Cocaine addiction_Homo sapiens_hsa05030 | 0.70067983 |
88 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.69757749 |
89 | Mineral absorption_Homo sapiens_hsa04978 | 0.68256061 |
90 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.68200048 |
91 | Long-term depression_Homo sapiens_hsa04730 | 0.66708981 |
92 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.65718607 |
93 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.65120520 |
94 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.64235577 |
95 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.64080613 |
96 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.62717090 |
97 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.61220166 |
98 | Olfactory transduction_Homo sapiens_hsa04740 | 0.59962854 |
99 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.59327475 |
100 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.58460160 |
101 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.58178213 |
102 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.57665867 |
103 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.57437692 |
104 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.56959387 |
105 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.56197744 |
106 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.54447702 |
107 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.54221377 |
108 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.52459599 |
109 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.52380302 |
110 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.51992882 |
111 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.51860759 |
112 | Prion diseases_Homo sapiens_hsa05020 | 0.51308002 |
113 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.51104530 |
114 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.51101788 |
115 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.47887096 |
116 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.47812275 |
117 | Insulin resistance_Homo sapiens_hsa04931 | 0.46692679 |
118 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.45198483 |
119 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.44419561 |
120 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.44101676 |
121 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.43273154 |
122 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.43230182 |
123 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.43047497 |
124 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.42881801 |
125 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.39433049 |
126 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.39136114 |
127 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.38896472 |
128 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.36788377 |
129 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.36482025 |
130 | Carbon metabolism_Homo sapiens_hsa01200 | 0.36094288 |
131 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.35671459 |
132 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.34651474 |
133 | Lysine degradation_Homo sapiens_hsa00310 | 0.34486039 |
134 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.34353714 |
135 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.34261026 |
136 | Axon guidance_Homo sapiens_hsa04360 | 0.34122867 |
137 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.33788137 |